CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 85.4% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Close

Trade AbbVie ABBV

AbbVie live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Aug 11, 15:00

Eli Lilly Beat Big and Raised Guidance. Wall Street Sees More Room to Run

AbbVie Inc
Webhose 2026 Aug 11, 12:43

FY2027 EPS Estimates for AbbVie Lowered by Erste Group Bank

AbbVie Inc
Webhose 2026 Aug 11, 11:05

AbbVie Piles on $8 Billion in Debt for Its Apogee Deal -- Should Dividend Investors Worry?

AbbVie Inc
Webhose 2026 Aug 11, 10:24

AbbVie Inc. $ABBV Position Cut by Handelsbanken Fonder AB

AbbVie Inc
Webhose 2026 Aug 11, 10:00

Allergan Aesthetics Refreshes Allergan Partner Privileges® to Better Support Today's Modern Aesthetics Practices | INN

AbbVie Inc
Webhose 2026 Aug 11, 10:00

KMG Fiduciary Partners LLC Cuts Stake in AbbVie Inc. $ABBV

AbbVie Inc
Webhose 2026 Aug 11, 09:31

E. Ohman J or Asset Management AB Buys 2,250 Shares of AbbVie Inc. $ABBV - Markets Daily

AbbVie Inc
Webhose 2026 Aug 11, 08:38

KMG Fiduciary Partners LLC Lowers Stake in AbbVie Inc. $ABBV - Stock Observer

AbbVie Inc
Webhose 2026 Aug 11, 08:17

Carolina Wealth Advisors LLC Purchases 7,626 Shares of AbbVie Inc. $ABBV

AbbVie Inc
Webhose 2026 Aug 11, 06:56

Generali Investments Management Co LLC Buys 2,671 Shares of AbbVie Inc. $ABBV - Stock Observer

AbbVie Inc
Webhose 2026 Aug 11, 04:46

Carolina Wealth Advisors LLC Buys 7,626 Shares of AbbVie Inc. $ABBV - Stock Observer

AbbVie Inc
Webhose 2026 Aug 11, 04:29

AbbVie Inc. $ABBV Stock Holdings Reduced by Handelsbanken Fonder AB - Daily Political

AbbVie Inc
Webhose 2026 Aug 11, 00:31

Big pharma sues to block Illinois drug discount law

AbbVie Inc
Webhose 2026 Aug 11, 00:00

Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer

AbbVie Inc
Webhose 2026 Aug 10, 16:59

AbbVie's (ABBV) Botox Just Got A Step Closer To A Fifth Use

AbbVie Inc
Webhose 2026 Aug 10, 12:00

3 Beaten-Down Healthcare Stocks to Buy in August

AbbVie Inc
Webhose 2026 Aug 10, 10:16

Sapient Capital LLC Sells 8,705 Shares of AbbVie Inc. $ABBV

AbbVie Inc
Webhose 2026 Aug 10, 10:05

Promising Pharmaceutical Stocks To Watch Now - August 10th - Daily Political

AbbVie Inc
Webhose 2026 Aug 10, 09:05

Biotech Stocks To Keep An Eye On - August 10th - Daily Political

AbbVie Inc
Webhose 2026 Aug 10, 06:29

AbbVie Inc. (NYSE:ABBV) Receives Average Recommendation of "Moderate Buy" from Brokerages

AbbVie Inc
Webhose 2026 Aug 09, 17:04

Promising Pharmaceutical Stocks To Follow Now - August 9th - Markets Daily

AbbVie Inc
Webhose 2026 Aug 09, 10:24

GoalVest Advisory LLC Sells 6,171 Shares of AbbVie Inc. $ABBV

AbbVie Inc
Webhose 2026 Aug 09, 08:24

Cardano Risk Management B.V. Buys 32,345 Shares of AbbVie Inc. $ABBV

AbbVie Inc
Webhose 2026 Aug 09, 07:04

Agate Pass Investment Management LLC Has $13.67 Million Stock Position in AbbVie Inc. $ABBV

AbbVie Inc
Webhose 2026 Aug 08, 13:21

AbbVie (NYSE:ABBV) Stock Price Down 1% - Here's What Happened - Zolmax

AbbVie Inc
Webhose 2026 Aug 08, 13:04

Healthcare Stocks To Consider - August 8th - Stock Observer

AbbVie Inc
Webhose 2026 Aug 08, 12:04

Biotech Stocks To Watch Now - August 8th - Stock Observer

AbbVie Inc
Webhose 2026 Aug 08, 10:24

MRA Advisory Group Purchases 5,215 Shares of AbbVie Inc. $ABBV

AbbVie Inc
Webhose 2026 Aug 08, 06:58

MRA Advisory Group Boosts Position in AbbVie Inc. $ABBV - Stock Observer

AbbVie Inc
Webhose 2026 Aug 08, 00:00

Exploring PDLIM2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma

AbbVie Inc
Webhose 2026 Aug 08, 00:00

Exploring the mixed marketing authorisation pathway: a case study in ophthalmology

AbbVie Inc
Webhose 2026 Aug 07, 20:44

AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?

AbbVie Inc
Webhose 2026 Aug 07, 20:14

AbbVie (ABBV) Is Down 5.3% After Raising 2026 Revenue Outlook and Issuing New Debt - What's Changed

AbbVie Inc
Webhose 2026 Aug 07, 10:08

Westmount Partners LLC Sells 6,457 Shares of AbbVie Inc. $ABBV

AbbVie Inc
Webhose 2026 Aug 07, 08:00

Assenagon Asset Management S.A. Grows Position in AbbVie Inc. $ABBV

AbbVie Inc
Webhose 2026 Aug 07, 08:00

Czech National Bank Has $126.55 Million Stock Position in AbbVie Inc. $ABBV

AbbVie Inc
Webhose 2026 Aug 07, 04:24

ABBV: Future Returns Will Hinge On Apogee Respiratory Bet

AbbVie Inc
Webhose 2026 Aug 07, 03:49

St. Louis Financial Planners Asset Management LLC Takes $5.01 Million Position in AbbVie Inc. $ABBV - Daily Political

AbbVie Inc
Webhose 2026 Aug 06, 21:20

AbbVie (NYSE:ABBV) Trading Down 1% - What's Next?

AbbVie Inc
Webhose 2026 Aug 06, 19:02

Regenxbio Inc (RGNX) (Q2 2026) Earnings Call Highlights: Cash Runway Extended into Q4 2027 on ...

AbbVie Inc
Webhose 2026 Aug 06, 18:59

M&A and AI power red-hot summer in dollars

AbbVie Inc
Webhose 2026 Aug 06, 16:05

The 6.4% Monthly Payer That Beat JEPI by 8 Points With No NAV Bleed

AbbVie Inc
Webhose 2026 Aug 06, 10:16

Sanders Morris Harris LLC Sells 18,921 Shares of AbbVie Inc. $ABBV

AbbVie Inc
Webhose 2026 Aug 06, 10:09

AbbVie Inc. $ABBV Shares Sold by Hamlin Capital Management LLC - Markets Daily

AbbVie Inc
Webhose 2026 Aug 06, 09:05

NewEdge Advisors LLC Buys 5,648 Shares of AbbVie Inc. $ABBV

AbbVie Inc
Webhose 2026 Aug 06, 06:09

AbbVie Inc. $ABBV is Hamlin Capital Management LLC's 7th Largest Position - Stock Observer

AbbVie Inc
Webhose 2026 Aug 06, 01:20

This Stock Keeps Raising Its Dividend No Matter What the Market Does -- and Wall Street Thinks It's a Buy Right Now

AbbVie Inc
Webhose 2026 Aug 05, 20:21

AbbVie (NYSE:ABBV) Stock Price Down 2.5% - Here's What Happened - Markets Daily

AbbVie Inc
Webhose 2026 Aug 05, 14:00

Prediction: AbbVie Will End The Year at This Price

AbbVie Inc
Webhose 2026 Aug 05, 12:17

Baron Capital Exits Apogee Therapeutics (APGE) Following AbbVie Buyout

AbbVie Inc
Webhose 2026 Aug 05, 08:17

Canandaigua National Bank & Trust Co. Acquires New Stake in AbbVie Inc. $ABBV

AbbVie Inc
Webhose 2026 Aug 05, 08:06

AbbVie (NYSE:ABBV) Raised to "Buy" at Erste Group Bank - Daily Political

AbbVie Inc
Webhose 2026 Aug 04, 22:11

AbbVie (ABBV) Wins FDA Review For BOTOX Cosmetic In Jawline Treatment Push

AbbVie Inc
Webhose 2026 Aug 04, 15:41

ABBV Q2 Deep Dive: Immunology and Neuroscience Expansion Shape Outlook Amid Guidance Reset

AbbVie Inc
Webhose 2026 Aug 04, 14:17

Allergan Aesthetics Seeks Fifth FDA Approval For BOTOX Cosmetic In Facial Contouring

AbbVie Inc
Webhose 2026 Aug 04, 13:09

AbbVie Seeks at Least $8 Billion in Debt to Fund Apogee Deal

AbbVie Inc
Webhose 2026 Aug 04, 11:05

Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One

AbbVie Inc
Webhose 2026 Aug 04, 10:48

AbbVie Inc. $ABBV is Meadowbrook Wealth Management LLC's 7th Largest Position - Zolmax

AbbVie Inc
Webhose 2026 Aug 04, 10:32

Neville Rodie & Shaw Inc. Sells 17,684 Shares of AbbVie Inc. $ABBV

AbbVie Inc
Webhose 2026 Aug 04, 10:16

AbbVie Inc. $ABBV Holdings Trimmed by Meadowbrook Wealth Management LLC

AbbVie Inc
Webhose 2026 Aug 04, 10:01

UBRELVY® (ubrogepant) Recommended for Reimbursement by Canada's Drug Agency (CDA-AMC) for Acute Migraine Treatment

AbbVie Inc
Webhose 2026 Aug 04, 10:00

Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence

AbbVie Inc
Webhose 2026 Aug 04, 09:05

Best Biotech Stocks To Watch Today - August 4th - Daily Political

AbbVie Inc
Webhose 2026 Aug 04, 08:09

CX Institutional Decreases Position in AbbVie Inc. $ABBV

AbbVie Inc
Webhose 2026 Aug 04, 00:53

Edgestream Partners L.P. Sells 58,230 Shares of AbbVie Inc. $ABBV - Daily Political

AbbVie Inc
Webhose 2026 Aug 04, 00:00

Navigating evidence-based recommendations for the management of systemic sclerosis

AbbVie Inc
Webhose 2026 Aug 03, 21:20

AbbVie (NYSE:ABBV) Shares Down 2.5% - Here's What Happened

AbbVie Inc
Webhose 2026 Aug 03, 21:05

AbbVie's Growth Now Leans On A Single Molecule

AbbVie Inc
Webhose 2026 Aug 03, 16:01

What Are Wall Street Analysts' Target Price for AbbVie Stock?

AbbVie Inc
Webhose 2026 Aug 03, 14:59

AbbVie Earnings: Maintaining Our Fair Value Estimate Following a Steady Second Quarter | Morningstar

AbbVie Inc
Webhose 2026 Aug 03, 13:06

AbbVie (NYSE:ABBV) Given New $285.00 Price Target at Cantor Fitzgerald - Markets Daily

AbbVie Inc
Webhose 2026 Aug 03, 13:06

AbbVie (NYSE:ABBV) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says

AbbVie Inc
Webhose 2026 Aug 03, 12:30

3 Top Dividend Stocks to Buy Before Their Next Payout

AbbVie Inc
Webhose 2026 Aug 03, 10:16

Sapient Capital LLC Has $44.56 Million Stake in AbbVie Inc. $ABBV

AbbVie Inc
Webhose 2026 Aug 02, 18:03

Best Pharmaceutical Stocks To Follow Today - August 2nd - Markets Daily

AbbVie Inc
Webhose 2026 Aug 02, 15:00

ABBV Stock: Q2 Dip Is a Buying Opportunity With $300 Ahead

AbbVie Inc
Webhose 2026 Aug 02, 15:00

AbbVie Quietly Solved Its Biggest Problem-Now What?

AbbVie Inc
Webhose 2026 Aug 02, 13:02

Best Biotech Stocks To Add to Your Watchlist - August 2nd - Stock Observer

AbbVie Inc
Webhose 2026 Aug 02, 08:44

Flagship Wealth Advisors LLC Reduces Stock Holdings in AbbVie Inc. $ABBV

AbbVie Inc
Webhose 2026 Aug 02, 08:17

First Nebraska Trust Co Buys Shares of 7,118 AbbVie Inc. $ABBV

AbbVie Inc
Webhose 2026 Aug 02, 08:11

Financial Solutions Advisory Group Inc. Purchases New Stake in AbbVie Inc. $ABBV - Markets Daily

AbbVie Inc
Webhose 2026 Aug 02, 08:10

9,761 Shares in AbbVie Inc. $ABBV Purchased by Financial Solutions Advisory Group Inc.

AbbVie Inc
Webhose 2026 Aug 02, 04:44

AbbVie (NYSE:ABBV) Shares Down 2.4% - What's Next? - Daily Political

AbbVie Inc

AbbVie news

Latest news

Info

Spread

1.62

Spread (%)

0.6509 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Wednesday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

438192078848

Shares Outstanding

1767117285

Earnings Date (Next)

0000-00-00

Div Yield

2026-08-14

Ex-Dividend Date

2026-07-15

Forward annual dividend rate

6.92

Forward annual dividend yield

0.0281

EPS

3.57

Learn more about this instrument

AbbVie AbbVie Inc
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's feet, forehead lines, and platysma bands; Juvederm Collection to treat volume loss in the temples, undereye, cheeks, chin, lips and lower face; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; Qulipta for episodic and chronic migraine; and Vyalev for the treatment of motor fluctuations, as well as Botox Therapeutic to treat chronic migraine, overactive bladder, spasticity, cervical dystonia, and other conditions. In addition, the company offers Ozurdex for visual impairment; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; and other eye care products, including Refresh/Optive, Xen, Durysta, and Restasis. Further, it provides Mavyret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Related Instruments

Asset
Sell
Buy
Change (%)

Latest Education Articles

Trustpilot